![]() |
|
searchpremium serviceseventsdirectory servicesadvertisingcustomer care |
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients Lonza Offers to Acquire Patheon6:31 AM MDT | August 21, 2009 | Deepti Ramesh Lonza says it has submitted a non-binding proposal to acquire all of the outstanding restricted voting shares of leading pharmaceutical contract manufacturing and development services company Patheon (Toronto) at a price of $3.55/share. The price offered by... This information is only available to Forgot your user ID or password?
|
Not an IHS Chemical Week
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|